All News #Library
Biotech
Latigo Bio Closes $150M Series B to Advance Pain Therapeutics
17 Mar 2025 //
PR NEWSWIRE
Latigo Biotherapeutics Appoints Timothy P. Walbert as Board Chair
19 Nov 2024 //
PR NEWSWIRE
Pain medicine biotech Latigo taps CRO founder for CMO role
20 Aug 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support